Lupin Launches Formoflo-G MDI, World's First Triple Combination COPD Inhaler in India
Lupin Ltd launches Formoflo-G MDI, the world's first fixed-dose triple combination inhaler for COPD in India, addressing a market of over 55 million patients.
ALFA News
Straight from the exchange filing
Lupin Ltd launches Formoflo-G MDI, the world's first fixed-dose triple combination inhaler for COPD in India, addressing a market of over 55 million patients.